Dogwood Therapeutics, Inc. (DWTX) Form 8-K Material Events
Dogwood Therapeutics, Inc. (DWTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DWTX
CIK: 1818844
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Forvis Mazars, LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDaniel Smith
Audit LocationAtlanta, Georgia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-096719 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003570 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001104659-26-095512 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-16 | 8-K | 0001104659-26-075204 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0001825983-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0001424620-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0001441661-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0001825986-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002141 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-061938 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001104659-26-060747 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001104659-26-049456 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-16 | DEF 14A | 0001104659-26-049277 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-17 | 2026-06-16 | PRE 14A | 0001104659-26-044776 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-26 | 8-K | 0001104659-26-034928 | View SEC Doc Filr Page |
| 10-K | 2026-03-18 | 2025-12-31 | 10-K | 0001104659-26-031061 | View SEC Doc Filr Page |
| 8-K | 2026-03-18 | 2026-03-18 | 8-K | 0001104659-26-029992 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-11 | 8-K | 0001104659-26-027090 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-05 | 4 Filing | 0001826084-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-05 | 4 Filing | 0001825987-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-05 | 4 Filing | 0001826131-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-05 | 4 Filing | 0001831127-26-000005 | View SEC Doc Filr Page |
| DEF 14A | 2026-02-13 | 2026-03-11 | DEF 14A | 0001104659-26-015180 | View SEC Doc Filr Page |
| EFFECT | 2026-01-29 | — | EFFECT Filing | 9999999995-26-000349 | View SEC Doc Filr Page |
| CORRESP | 2026-01-27 | — | CORRESP Filing | 0001104659-26-007009 | View SEC Doc Filr Page |